UK markets close in 3 hours 28 minutes

CVS Health Corporation (0HRS.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
97.54-0.07 (-0.08%)
As of 05:55PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3N/A
S&P500 52-week change 3-16.03%
52-week high 398.10
52-week low 396.90
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.02B
Implied shares outstanding 6N/A
Float 81.31B
% held by insiders 10.38%
% held by institutions 180.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.10
Trailing annual dividend yield 32.15%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 2.66%
Operating margin (ttm)4.71%

Management effectiveness

Return on assets (ttm)3.91%
Return on equity (ttm)10.94%

Income statement

Revenue (ttm)306.93B
Revenue per share (ttm)233.05
Quarterly revenue growth (yoy)11.30%
Gross profit (ttm)50.85B
EBITDA 18.83B
Net income avi to common (ttm)8.17B
Diluted EPS (ttm)6.01
Quarterly earnings growth (yoy)6.00%

Balance sheet

Total cash (mrq)14.99B
Total cash per share (mrq)11.42
Total debt (mrq)74.17B
Total debt/equity (mrq)98.23
Current ratio (mrq)0.91
Book value per share (mrq)57.31

Cash flow statement

Operating cash flow (ttm)18.53B
Levered free cash flow (ttm)14.16B